baber/WOPTO huggingface dataset:
Patent IE-820241-L (IE)
Title: Substituted imidazoles
IPC: C07D233/64
Filed: 1982-02-03
Abstract: Compounds of the formula:   <IMAGE> (I)   <IMAGE>  wherein each of R1, R2 and R3, which can be the same or different, is hydrogen, chloro, bromo, fluoro, methyl, ethyl, methoxy, amino, hydroxy or nitro; R4 is hydrogen or alkyl of 1 to 7 carbon atoms; R5 is hydrogen or a straight or branched alkyl group of 1 to 5 carbon atoms or a phenyl group; and R6 is hydrogen or an alkyl group of 1 to 7 carbon atoms or a substituted or unsubstituted benzyl, X is -CH2-, -CHOH- or -CH=CH- and n is 0-4; provided that R5 and R6 are simultaneously hydrogen only when n is 4 and X is -CH=CH-; and their non-toxic pharmaceutically acceptable acid addition salts and mixtures thereof exhibit valuable pharmacological activity and are useful in the treatment of mammals, especially as antithrombotic agents. Furthermore, some of the compounds have proved to possess antihypertensive or  beta -blocking activity. Antimicrobial and antifungal properties have also been found. Processes for the preparation of these compounds are described, as are novel pharmaceutical compositions comprising at least one of the compounds or their salts.
Patent IE-790285-L (IE)
Title: Artificial cream composition
IPC: A23L9/20
Filed: 1979-02-14
Abstract: Artificial creams essentially free from milk proteins are particularly suitable as coffee creams and comprise an emulsion of edible fat, especially containing up to about 30% lauric fat, with an emulsifier system comprising a mixture of lecithin with selected nonionic and an ionic emulsifier preferably having a predetermined range of HLB activity.
[US4360535A]
Patent IE-790556-L (IE)
Title: Benzylidene derivatives
IPC: A61K31/195
Filed: 1979-08-08
Abstract: Compounds corresponding to the formula (I> <IMAGE> in which X1, X2, X3 and X4 each represent, independently of one another, a hydrogen or halogen atom or a radical CH3, CH3O, NO2, CF3, C(CH3)3 or CH3CONH, n represents an integer ranging from 1 to 10, R is a radical OH, OM (M=alkali metal), NH2, NH-cycloalkyl, NH-phenyl, NH-benzyl, NH-alkyl, N-(alkyl)2 or N-(alkyl)- (benzyl), and R' represents a hydrogen atom or an alkyl, the alkyls having from 1 to 4 carbon atoms, with the exception of the compounds in which R'=H when X1, X2 and X3 are each, independently of one another, H, Hal, CH3 or CH3O and X4=H and with the exception of the compound in which R'=H, X1=X3=X4=H, X2=5-Cl, n=1 and R=OH. The compounds are anti- convulsants and are useful in treating disorders of the central nervous system, e.g. epilepsy. Processes for preparing them and pharmaceutical compositions containing them are also claimed.
[GB2021559A]
Patent IE-42577-L (IE)
Title: Controlling ac-motors
IPC: H02P29/00
Filed: 1976-04-26
Abstract: An apparatus for controlling an AC-motor, with a feedback arrangement in which the feed-back signal is the output signal of a partly mechanical pulse generator coupled to the shaft of the motor, comprising a micro-processor to which is fed a feed-back signal and a reference signal and a digital clock which sends output signals to said micro-processor, said micro-processor generating signals through a first set of output controls for controlling the frequency and phase of the AC-power supplied to the motor by comparing the reference signal and the arrival times of the feed-back pulses as indicated by the digital clock. (From US4099107 A) [GB1540997A]
Patent IE-32229-L (IE)
Title: Diamond compacts
IPC: B01J3/06
Filed: 1968-07-29
Abstract: 1,240,525. Diamonds. GENERAL ELECTRIC CO. 1 Aug., 1968 [8 Sept., 1967], No. 36801/68. Heading C1A. Polycrystalline diamond compacts containing not more than 2% by wt. of material other than diamond, having a density in excess of 91% of the theoretical and being substantially homogeneous are produced by either: (i) heating fine diamond particles at a temp. of 600-900 C., or (ii) bombarding fine diamond particles with +ve ions in an inert atmosphere (as defined) at subatmospheric pressures. After either of these two treatments the diamonds are compacted at a pressure >50 kilobars and a temp. of 1300 C. Fig. 1 is a diagram of the equipment required for either of the first two treatments. 1 is a pan of Mo, Co, Ti on which the diamonds are placed. For ion bombardment anode 4 and the pan 1 acting as cathode are wired to a D.C. supply which produces a voltage differential of between 1500 and 1800 volts. Agitation of the cathode can be carried out by a solenoid-actuated vibrator 8. For the heating process, a resistance heater 9 beneath the pan is used. Fig. 2 is a diagram of the reaction vessel for use in the high pressure, high temp., compacting step. The reaction vessel 17 is of the indirectly heated type having a pyrophyllite outer cylinder 18 and a graphite heating tube 19. Another cylinder 20 of alumina is placed inside the heating tube and a liner 21 of graphite is placed inside the alumina cylinder. Matrix materials that may be used to form the compacts are B, Ta, Mo, Ti or their carbides or borides. The compact however should not contain more than 2% by wt. of matrix material. The sintering stage is carried out in an inert atm. or preferably a reducing atm. An inert atmosphere is defined as an atmosphere free from oxygen, nitrogen and water vapour.
[GB1240525A]
Patent FI-852443-L (FI)
Inventor: JANSSON TAGE
IPC: B31B50/64
Filed: 1985-06-19
Abstract: Device for the manufacture of tubular packaging cases that have a rounded shape and are made from cardboard or similar material from a plane container blank 7, comprising a fixed mandrel 2, around which the container casing 7 is designed to be bent and closed to form an integrated case, two bending arms 8, over which a spring loaded bending strip 20 extends, guide block 16 with guide grooves 17 for positive rotation of the bending arms 8 together with the bending strip 20 and a casing blank 7 along the periphery of the mandrel 2, and elements 13, 14 for moving the bending arms 8 in relation to the mandrel 2 at the same time as the bending arms 8 are rotated. The stroke length of the movement of the bending arms to and from the mandrel and the location of the guide block 16 with the guide grooves 17 can be adjusted in order to adapt the device for the manufacture of container casings of various sizes and/or shapes. <IMAGE>
Patent IE-781173-L (IE)
Title: Stiffening shoe uppers
IPC: A43D11/01
Filed: 1978-06-09
Abstract: Process for stiffening a selected are of flexible sheet material, particularly a part such as the counter portion of a shoe upper, in which a predetermined quantity of hot molten resin is deposited on the area as a body of substantial thickness, the area is pressed to spread out and adhere the resin as a layer and thereafter the resin is cooled to a stiff resilient condition. The sheet material may be removed from the first pressing operation and subjected to a second pressing or molding operation around a form such as a last. In this second pressing, molten resin which has been squeezed from the area onto the lasting margin, by controlled conditions in the first pressing may be employed as lasting cement by wiping down the lasting margin against the bottom surface of an insole.
[US4127910A]
Patent IE-32892-L (IE)
Title: Chlorinated vinyl chloride composition
IPC: C08L27/24
Filed: 1968-10-04
Abstract: Hardening of aminoplasts is carried out by adding sultones to solutions or emulsions of precondensates. The resin is hardened in known manner at elevated temp.
[DE1801004A1]
Patent IE-39410-L (IE)
Title: Anesthetic compositions and their use
IPC: A61K31/505
Filed: 1974-06-10
Abstract: Vertebrates can be anesthetized regionally by a subarachnoid administration of tetrodotoxin or desoxytetrodotoxin. The amount of tetrodotoxin which should be administered in a preferred embodiment ranges between 1 and 12 micrograms, whereas the amount of desoxytetrodotoxin ranges between 10 and 120 micrograms.
[US3898339A]
Patent IE-45325-L (IE)
Title: Anti-inflammatory thiophene derivatives
IPC: C07D333/22
Filed: 1977-07-29
Abstract: The compounds of the formula I are obtained by reacting a compound of the formula VI with an acylating derivative of a thienylcarboxylic acid or by reacting thiophene with an acylating derivative of an acid of the formula VII. The compounds which are obtained exhibit an antiinflammatory effect and, in contrast to the acidic antiinflammatory agents, exhibit less tendency to cause gastrointestinal irritations. <IMAGE>
[GB1525434A]
Patent IE-39655-L (IE)
Title: Polyamides containing sulphonate groups
IPC: C08G69/00
Filed: 1974-08-06
Abstract: 1475807 Basic-dyeable polyamides BAYER AG 6 Aug 1974 [7 Aug 1973] 34543/74 Heading C3A N,N<SP>1</SP> - bis(2 - sulphenatobenzyl) - hexamethylene diamine which has been prepared by reacting 2-sulphonatobenzaldehyde with hexamethylene diamine followed by catalytic hydrogenation is used in the preparation of polymers of caprolactam also containing monomeric units such polymers having a R.V. of 1À1 to 3À5 (1 g./dl. in m-cresol at 25 C.) and contains 40 to 2000 m.val./kg. of sulphonate groups. In the formula M is an alkali metal and R is C 4-12 alkylene or It is stated that the specified preparation in contrast to the prior art procedure of sulphonation after reacting. The aldehyde and amine gives the pure 2-isomer which is more easily condensed into the polyamide and permits a higher concentration of sulphonate groups. The products can be used as concentrates to modify the basic dye-ability of unmodified coprolactam. Reference is made to Specification 1,149,842.
[GB1475807A]
Patent IE-811775-L (IE)
Title: Pyrrolobenzazepines.
IPC: C07D207/335
Filed: 1981-08-14
Abstract: Pyrrolo (3,4-d) benzazepine derivs. (I) and their acid addn. salts where A is a group of formula (Ia) are new: A is a group of formula (Ia), (Ib), (Ic), (Id) or (Ie); R1 is H, lower alkyl 3-7C alkenyl, 3-7C alkynyl, CH2OH or -CO-R11; R11 is H, OH, alkoxy, NH2 or mono- or di (lower) alkyl imino; R3 is H, lower alkyl, 3-7C alkenyl, 3-7C alkynyl, CH2OH or -CO-R111; R111 is H, OH, trihalomethyl, alkoxy, NH2 or mono- or di(lower alkyl)amino; R2 is H, lower alkyl, 3-7C alkenyl, 3-7C alkynyl, -COO (lower alkyl), a 2-7C carboxylic acid residue or ester or amide thereof, hydroxy-(2-7C alkyl), or amino- or mono- or di(lower alkyl)amino (2-7C alkyl); R5 is H, F, Cl or Br; R6 is F, Cl or Br; R95 is lower alkyl; and Z is the anion of an acid. Provisos are that (a) when one of R1 and R3 is hydroxymethyl, -CO-R11 or -CO-R111 then the other of R1 and R3 is H, lower alkyl, 3-7C alkenyl or 3-7C alkynyl and R2 is H, (b) when R4 is acyloxy, then R1 and R3 are H, lower alkyl, 3-7C alkenyl or 3-7C alkynyl and R2 is -CO-(lower alkoxy), (c) when R4 is OH then R1 and R3 are H, lower alkyl, 3-7C alkynyl or 3-7C alkenyl and R2 is H, (d) when R4 is unbranched lower alkoxy, then R1 and R3 are H, lower alkyl 3-7C alkenyl or 3-7C alkynyl, (e) when A is a group (Ib), (Ic), (Id) or (Ie), then R4 is H and (f) when A is a group (Ib) or (Ie), then R2 is other than amino- or mono- or di- (lower alkyl) amino- (2-7C alkyl)). Also new and claimed are intermediates to (I) and their precursors (I) have sedative and anxiolytic activity.
[EP0045519A2]
Patent IE-882430-L (IE)
Title: Compounds, process and use
IPC: C09D7/12
Filed: 1988-08-09
Abstract: A halogenated ethylene compound of the formula: X CR1R2C(Y1) = C(Y2)CR1R2 SCN where R1 and R2 are hydrogen, optionally substituted alkyl or together form a cyclohexyl group; X is bromine, chlorine or iodine and Y1 and Y2 are chlorine, bromine or iodine. A compound of this type is 2,3-dibromo-1-chloro-4-thiocyanato-2-butene. The compound has good anti-fungal and anti-bacterial properties. The compound can be used as an industrial biocide.
[EP0316058A1]
Patent NO-811998-L (NO)
Inventor: MODONE EROS
IPC: C03C13/00
Filed: 1981-06-12
Abstract: Process for reducing hydroxyl-group content in preforms for optical fibres, manufactured by MCVD process, consisting of isotopic exchange between hydrogen and deuterium near the internal walls of the silica-glass supporting tube (8). The operation is carried out in two steps, first by inducing deuterium adsorption and then by termally activating the exchange reaction.
Patent NO-834149-L (NO)
Inventor: BUTLER DONALD E
IPC: A61K31/4015
Filed: 1983-11-14
Abstract: 1-Aroyl-5-oxo-2-pyrrolidinepropanoic acids, salts, and esters which are useful as pharmacological agents, especially as agents for the reversal of amnesia, enhancing performance in poorly motivated subjects and treatment of senility and methods for their preparations are disclosed. Pharmaceutical compositions containing said compounds, salts, and esters and methods for using said compositions in treating senility, improving motivation and reversal of amnesia are also taught. The novel compounds have the formula:where R, X and Y are hydrogen atoms or various substituents, but R, X and Y are not simultaneously all hydrogen atoms.
Patent NO-854143-L (NO)
Inventor: WILLNERS HARRY
IPC: H05B3/00
Filed: 1985-10-18
Abstract: PCT No. PCT/SE85/00083 Sec. 371 Date Oct. 21, 1985 Sec. 102(e) Date Oct. 21, 1985 PCT Filed Feb. 19, 1985 PCT Pub. No. WO85/03834 PCT Pub. Date Aug. 29, 1985.The height position of three-phase electrodes R, S, T immersed in a resistive medium is controlled first in dependence of the values for the equivalent star network load impedances  &upbar& ZRO,  &upbar& ZSO,  &upbar& ZTO of the electrodes, these impedances being calculated on the basis of measured values representative of valid delta network load impedances &upbar& ZRS,  &upbar& ZST and  &upbar& ZTR of the electrodes. The height positions of the electrodes are then equalized by selective adjustment of the electrical conductivity of the resistive medium at respective electrodes, preferably by using the so-called derivative method.
Patent NO-863457-L (NO)
Inventor: BROWN ROGER CHARLES
IPC: C07D285/12
Filed: 1986-08-28
Abstract: There are described compounds of formula I,   <IMAGE> I  in which Y is S, O or NR9, n is 0 or 1, R9 is hydrogen or alkyl C 1 to 10, R3 is hydrogen, alkyl C 1 to 10, cycloalkyl C3 to 10, CF3, SR10, a 5 or 6 membered heterocyclic group containing one or more S, O or N atoms, NR4R5, phenyl or phenylalkyl C7 to 12, the phenyl, phenylalkyl and heterocyclic groups optionally being fused to a further phenyl group, the heterocyclic group and any phenyl group optionally being substituted by alkyl C 1 to 6, halogen, alkoxy C 1 to 6, nitro, nitrile, CF3, SR6, NR7R11 or hydroxy, R6, R7 and R11, which may be the same or different, are each hydrogen or alkyl C 1 to 10, R4 and R5, which may be the same or different, are each hydrogen, alkyl C 1 to 10 or phenyl, R10 is alkyl C 1 to 10, X1 is S or O, and A is a chain comprising from 2-16 atoms, which chain carries an O or S containing substitutent at a position 2-6 atoms away from the group C=X1, and pharmaceutically acceptable salts, esters and amides thereof, p1 there are also described method of making the compounds and pharmaceutical formulations, e.g. for the treatment of hypertension, containing them.
Patent NO-874373-L (NO)
Inventor: SMITH DONALD FOSS
IPC: C08K3/22
Filed: 1987-10-20
Abstract: Novel vinyl chloride copolymers including a hydroxyalkyl acrylate or methacrylate or allyl alcohol, an acid functionality from carboxylic acid-containing monomers and optionally an epoxy-containing vinyl monomer in selected propotions provide suitable binder resins for applications such as magnetic recording media, imparting enhanced dispersion and magnetic property characteristics while also having desirable rheological characteristics and, when the epoxy-containing vinyl monomer is used, desirable thermal stability.
Patent NO-883062-L (NO)
Inventor: VERHOEVEN THOMAS R
IPC: C07D309/30
Filed: 1988-07-08
Abstract: A process for alkylating the alpha position of the 8-acyl side chain in mevinolin and analogs thereof is disclosed. The process proceeds with a single charge of base and alkyl halide to give products with a pharmaceutically acceptable purity.
Patent NO-894134-L (NO)
Inventor: SAMRETH SOTH
IPC: A61K31/7034
Filed: 1989-10-17
Abstract: The present invention relates, by way of novel industrial products, to the  beta -D-phenylthioxyloside compounds of the formula   <IMAGE> (I)  in which: X represents a sulfur atom or an oxygen atom; R1, R2 and R3, which are identical or different, each represent a hydrogen atom, a nitro group, a cyano group, a group -CO-R (in which R represents a C1-C4 alkyl group or a trifluoromethyl group), an amino group, an acetamido group (NHCOCH3), a C1-C4 alkoxy group, a trifluoromethyl group or a phenyl group substituted by one or more cyano, nitro or trifluoromethyl groups, it being possible for R1 and R2, taken together, to form, with the phenyl group to which they are bonded, a  beta -naphthalenyl group which is unsubstituted or substituted by one or more cyano, nitro or trifluoromethyl groups; and Y represents the hydrogen atom or an aliphatic acyl group. These compounds are useful as therapeutic agents, especially as venous antithrombotics.
Patent NO-903537-L (NO)
Title: Fremgangsmaate og probe for in vitro paavisning av den ringformede partikkel og kreft hos mennesker og dyr.
Inventor: GUERRERO ROBERT R
IPC: G01N33/577
Filed: 1990-08-10
Abstract: In vitro fremgangsmåte og probe for bestemmelse av tilstede- værelsen av tumormarkøren ringformet partikkel (RSP) og for påvisning av tilstedeværelsen av ondartethet hos mennesker og dyr, omfatter oppfanging -av markøren fra en biologisk væske som inneholder kreftceller, på et substrat og påvisning av tilstede- værelsen av RSP-tumormarkøren på substratet som en indikator for til- stedeværelsen av ondartetheten. En foretrukket fremgangsmåte omfatter anvendelse av et anti-RSP-antistoff (rspAb) valgt fra ett eller flere av de monoklonale, polyklonale og affi- nitetsrensede antistoffer for å fange opp tumormarkøren fra en prøve av en biologisk væske, slik som blodserum, spytt, urin, utskyllingsvæsker etc. Tumormarkøren fanges opp på et substrat med et rspAb, og dens til- stedeværelse på substratet påvises ved å bruke vanlige påvisnings- systemer, slik som fargefremkal- lingsteknikker. Ved en foretrukket utførelsesform påvises tumormarkøren på substratet ved omsetning med en probe av tRNA-fotobiotin-streptavi- din-alkalisk fosfatase. En annen foretrukket fremgangsmåte omfatter anvendelse av en probe av over- føringsribonukleinsyre (tRNA) som er spesifikk for det aminoacylover- førings-RNA-syntetasereaktive sete på markøren, og påvisning av tilstede- værelsen av RSP ved fargefremkal- lingsteknikker under anvendelse av en probe av tRNA-fotobiotin-streptavi-din-alkalisk fosfatase.
Patent NO-911442-L (NO)
Inventor: CHEMINAL BERNARD
IPC: C07C17/20
Filed: 1991-04-12
Abstract: Process for the manufacture of 1,1,1,2-tetrafluorochloroethane and of pentafluoroethane. The process, which consists of the catalytic gas-phase fluorination of at least one pentahaloethane of formula C2HX2-nF3+n in which X denotes a chlorine or bromine atom and n the number 0 or 1, by means of hydrofluoric acid, is characterised in that a catalyst consisting of a catalytic quantity of chromium in an oxidation state equal to or higher than 3 and of an active carbon as support is employed. The selectivity for 1,1,1,2-tetrafluorochloroethane and pentafluoroethane reaches approximately 95 % and even more.
Patent NO-913156-L (NO)
Inventor: ITEN THOMAS
IPC: G06F3/00
Filed: 1991-08-13
Abstract: The keyboard has a basic membrane (3) and a cover membrane (4) which are connected to one another. Between these membranes, bubble-like chambers (6) are formed at the individual keys (1, 2). Each chamber (6) contains a piezoelectric element (5) which generates an electrical signal when a virtually zero-travel mechanical load is applied. The flat keyboard is simple to produce and has a reduced thickness. It is largely insensitive to the effect of moisture and mechanical fatigue. <IMAGE>
Patent NO-922354-L (NO)
Inventor: BRECHBUEHLER FRITZ
IPC: E04G9/10
Filed: 1992-06-16
Abstract: The device for limiting a shuttering end face comprises a precast element (1) of a width (W) which corresponds to the thickness of the concrete structure to be erected and of a modular length (L). The element (1) has openings (2) for fitting through reinforcing bars (3), lines (4) or pipes. Since the element is intended to remain in the masonry, it is expediently fabricated from a relatively fine concrete, contained in which is a reinforcing mesh (5) of plastic which also extends over the openings (2) and, in addition, prevents concrete from flowing to the outside when the said concrete is introduced. 
<??>Such a terminating element permits rapid and exact limiting of the shuttering if the masonry is not concreted in one piece or in the case of crane clearances and, moreover, does not require shuttering when concreting the adjoining part. 
<IMAGE>
Patent NO-940148-L (NO)
Inventor: SPEAR DAN
IPC: G06F/
Filed: 1994-01-14
Abstract: A method of increasing the amount of directly addressable memory address locations that can be allocated to RAM. An initialization routine is executed to identify ROM's in reserved memory address space that are to be reallocated. Suitable address space in extended memory is located and the ROM's are mapped into extended memory address space. A ROM access interceptor routine is implemented to trap ROM accesses and direct them to the reallocated address space. A ROM access handler routine is implemented to contain the ROM execution and to restore the computer system to a condition where it can continue execution of application or system software after the ROM access is completed. Memory addresses in reserved address space formerly allocated to ROM's can be reallocated to RAM or other memory devices.
Patent NO-940187-L (NO)
Title: Polyetylenblanding, samt film og komposittfilm omfattende denne
Inventor: NAITO YUKIO
IPC: C08L23/08
Filed: 1994-01-19
Abstract: Polyecylenblanding omfattende (I) fra 60 - 99 vektdeler av en randomisert etylen- a-olefinkopolymer omfattende etylen og et a-olefin med fra 4-10 karbonatomer, idet kopolymeren har et a-olefininnhold fra 2,0 - 10 mol% og en densitet fra 0,895 - 0,915 g/cm3, og (II) fra 1-40 vektdeler av et høydensitets-polyetylen med en densitet på minst 0,945 g/cm3. Det beskrives også en film og en komposittfilm om- fattende ovennevnte blanding.
Patent NO-941644-L (NO)
Title: Fremgangsmåte og anordning for sammensveising av rör
Inventor: VAN HEUVELN JOOST
IPC: B23K37/053
Filed: 1994-05-04
Abstract: Oppfinnelsen vedrører en fremgangsmåte for sairjnen- sveising av minst to rør som er anordent koaksialt med hverandre akse, hvor en ledering anbringes rundt minst ett av de to rør, og hvor en bærer av minst en sveiselampe ført av lederingen beveges i periferisk retning av rørene, mens minst en sveisestreng påfø- res. Denne oppfinnelse har til hensikt å underlette sveiseoperasjonene og/eller å øke kvaliteten på sveisen. For dette formål beveges sveiselampen i forhold til lederingen ved hjelp av minst en regulert rotasj onsmotor. Oppfinnelsen tilveiebringer også en anordning som er spesielt beregnet på utførelse av fremgangsmåten i henhold til oppfinnelsen. Foreliggende oppfinnelse kan anvendes ved sveising av kjeler og kar hvor en ringsveis anvendes mellom to elementer utformet som rør med sylindriske kanter. ; Oppfinnelsen kan imidlertid anvendes spesielt fordel- aktig i en fremgangsmåte og anordning for legging av e"n rørledning.